Sponsor study identifier
interventional
36
1 country
2
Study Start
July 1, 2020
Actual (reported)Primary Completion
October 30, 2020
Actual (reported)Study Completion
November 1, 2020
Actual (reported)Postoperative delirium is a complication that should not be underestimated. As it elaborates many complications that could be avoided when an accurate assessment of the risk factors and interventional measures are taken appropriately when needed.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 1, 2020
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 1, 2020
Actual (reported)October 30, 2020
Actual (reported)November 1, 2020
Actual (reported)January 6, 2022
Actual (reported)February 11, 2022
Actual (reported)The efficacy of oral Melatonin in preventing Postoperative Delirium after general anesthesia
This interventional trial is done to determine the efficacy of preoperative melatonin administration in reducing postoperative delirium rates.
1 week
Patients in this group received nothing for sedation.
7.5 mg of Midazolam were given orally the night before operation. Another dose 90 min. preoperatively.
5 mg of Melatonin were given orally the night before operation. Another dose 90 min. preoperatively
The patients were assessed using the Memorial Delirium Assessment Scale (MDAS) after the operation at 30, 60, and 90 min. Melatonin was shown to reduce delirium from 41.6% to 16.6% at 60 minutes, and the significant reduction was at 90 minutes (0%) when compared to both groups. Thus, melatonin was found to be successful in decreasing postoperative delirium when administered preoperatively.
Al-Kadhemya Private Hospital
Baghdad, 10047, Iraq
Ghazi Al-Hariri Teaching Hospital
Baghdad, 10047, Iraq
36 participants (actual enrollment reported by the registry).
First Submitted
January 6, 2022
First Posted
February 11, 2022
Study Start
Prevention of Postoperative Delirium After Acute Surgery
No intervention was used.
7.5 mg of Midazolam orally.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
July 1, 2020
Actual (reported)Primary Completion
October 30, 2020
Actual (reported)Study Completion
November 1, 2020
Actual (reported)Last Updated
February 11, 2022
Record last verified: 2022-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: